Citius Oncology (CTOR) Inventory Average (2024 - 2026)

Citius Oncology (CTOR) has reported Inventory Average for 3 consecutive years, with $22.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 39.13% year-over-year to $22.6 million in Q2 2026; TTM through Jun 2026 was $22.6 million, a 39.13% increase from a year earlier, with the FY2025 full-year figure at $15.3 million, changed N/A from the prior year.
• Inventory Average was $22.6 million for Q2 2026 at Citius Oncology, roughly flat from $22.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $22.6 million in Q1 2026 and troughed at $11.3 million in Q4 2024.
• A 3-year average of $18.6 million and a median of $19.7 million in 2025 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average soared 98.35% in 2025 and surged 39.13% in 2026, its largest moves.
• Over 3 years, Inventory Average stood at $11.3 million in 2024, then soared by 98.35% to $22.5 million in 2025, then gained by 0.8% to $22.6 million in 2026.
• The last three Inventory Average figures came in at $22.6 million (Q2 2026), $22.6 million (Q1 2026), and $22.5 million (Q4 2025), per Business Quant data.